Doseology Sciences Inc. (MOOD.CN)
CAD 0.4
(8.11%)
CAD 0.4
(8.11%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | - CAD | -100.0% |
| 2022 | 50.27 Thousand CAD | -93.26% |
| 2021 | 746.09 Thousand CAD | 8.52% |
| 2020 | 687.54 Thousand CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q4 | - CAD | 0.0% |
| 2023 Q1 | 41.73 Thousand CAD | -16.99% |
| 2023 Q2 | - CAD | -100.0% |
| 2023 Q3 | - CAD | 0.0% |
| 2022 Q1 | 516.97 Thousand CAD | -30.71% |
| 2022 Q4 | 50.27 Thousand CAD | -89.59% |
| 2022 Q3 | 482.76 Thousand CAD | -3.47% |
| 2022 Q2 | 500.13 Thousand CAD | -3.26% |
| 2022 FY | 50.27 Thousand CAD | -93.26% |
| 2021 Q2 | 817.62 Thousand CAD | 20.12% |
| 2021 FY | 746.09 Thousand CAD | 8.52% |
| 2021 Q4 | 746.09 Thousand CAD | -2.04% |
| 2021 Q3 | 761.6 Thousand CAD | -6.85% |
| 2021 Q1 | 680.67 Thousand CAD | -1.0% |
| 2020 Q4 | 687.54 Thousand CAD | 0.0% |
| 2020 FY | 687.54 Thousand CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | - CAD | NaN% |
| Asep Medical Holdings Inc | 20 Thousand CAD | 100.0% |
| BetterLife Pharma Inc. | 245.23 Thousand CAD | 100.0% |
| BioVaxys Technology Corp. | - CAD | NaN% |
| ChitogenX Inc. | 3.87 Million CAD | 100.0% |
| Rapid Dose Therapeutics Corp. | 2.45 Million CAD | 100.0% |
| Defence Therapeutics Inc. | 1.74 Million CAD | 100.0% |
| Entheon Biomedical Corp. | - CAD | NaN% |
| Gemina Laboratories Ltd. | 285.32 Thousand CAD | 100.0% |
| Glow Lifetech Corp. | 116.18 Thousand CAD | 100.0% |
| Lexston Life Sciences Corp. | - CAD | NaN% |
| Pharmala Biotech Holdings Inc. | 253.53 Thousand CAD | 100.0% |
| MYND Life Sciences Inc. | 3 Million CAD | 100.0% |
| Nova Mentis Life Science Corp. | - CAD | NaN% |
| PharmaTher Holdings Ltd. | - CAD | NaN% |
| PreveCeutical Medical Inc. | 3.83 Million CAD | 100.0% |
| Telescope Innovations Corp. | - CAD | NaN% |